Advanced search
Publication Cover
OncoTargets and Therapy Volume 11, 2018 - Issue
Submit an article Journal homepage
88
Views
12
CrossRef citations to date
0
Altmetric
Original Research

SRPK1 is a poor prognostic indicator and a novel potential therapeutic target for human colorectal cancer

Nan Yi1 Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, People’s Republic of China, [email protected];2 Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, People’s Republic of China
,
Mingbing Xiao1 Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, People’s Republic of China, [email protected];2 Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, People’s Republic of China
,
Feng Jiang2 Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, People’s Republic of China
,
Zhaoxiu Liu2 Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, People’s Republic of China
,
Wenkai Ni2 Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, People’s Republic of China
,
Cuihua Lu2 Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, People’s Republic of China
,
Runzhou Ni2 Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, People’s Republic of China
&
Weichang Chen1 Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, People’s Republic of China, [email protected]Correspondence[email protected]
 show all
Pages 5359-5370 | Published online: 03 Sep 2018

References

  • SchiffGDBeardenTHuntLSPrimary care collaboration to improve diagnosis and screening for colorectal cancerJt Comm J Qual Patient Saf201743733835028648219
  • De RosaMPaceURegaDGenetics, diagnosis and management of colorectal cancer (Review)Oncol Rep20153431087109626151224
  • PancioneMRemoAColantuoniVGenetic and epigenetic events generate multiple pathways in colorectal cancer progressionPatholog Res Int2012201250934822888469
  • LongJCCaceresJFThe SR protein family of splicing factors: master regulators of gene expressionBiochem J20094171152719061484
  • BradleyTCookMEBlanchetteMSR proteins control a complex network of RNA-processing eventsRNA2015211759225414008
  • da SilvaMRMoreiraGAGoncalves da SilvaRASplicing regulators and their roles in cancer biology and therapyBiomed Res Int2015201515051426273588
  • AminEMOlteanSHuaJWT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicingCancer Cell201120676878022172722
  • ZhouZQiuJLiuWThe Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleusMol Cell201247342243322727668
  • GhoshGAdamsJAPhosphorylation mechanism and structure of serine-arginine protein kinasesFEBS J2011278458759721205204
  • WangPZhouZHuABoth decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of AktMol Cell201454337839124703948
  • XuQLiuXLiuZMicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathwayMol Cancer201716110328606154
  • GammonsMVLucasRDeanRCouplandSEOlteanSBatesDOTargeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanomaBr J Cancer2014111347748525010863
  • MavrouABrakspearKHamdollah-ZadehMSerine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancerOncogene201534334311431925381816
  • van RoosmalenWLe DévédecSEGolaniOTumor cell migration screen identifies SRPK1 as breast cancer metastasis determinantJ Clin Invest201512541648166425774502
  • WangFZhouJXieXInvolvement of SRPK1 in cisplatin resistance related to long non-coding RNA UCA1 in human ovarian cancer cellsNeoplasma201562343243825967360
  • GongLSongJLinXSerine-arginine protein kinase 1 promotes a cancer stem cell-like phenotype through activation of Wnt/β-catenin signalling in NSCLCJ Pathol2016240218419627391422
  • HanXYangJJiaZKnockdown of serine-arginine protein kinase 1 inhibits the growth and migration in renal cell carcinoma cellsOncol Res201725338939527662590
  • XuXWeiYWangSLuoMZengHSerine-arginine protein kinase 1 (SRPK1) is elevated in gastric cancer and plays oncogenic functionsOncotarget2017837619446195728977917
  • GonçalvesVHenriquesAFPereiraJFPhosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cellsRNA201420447448224550521
  • LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT methodMethods200125440240811846609
  • BatsonJToopHDRedondoCDevelopment of potent, selective SRPK1 inhibitors as potential topical therapeutics for neovascular eye diseaseACS Chem Biol201712382583228135068
  • SiegelRLMillerKDFedewaSAColorectal cancer statistics, 2017CA Cancer J Clin201767317719328248415
  • HayesGMCarriganPEMillerLJSerine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomasCancer Res20076752072208017332336
  • BullockNPottsJSimpkinAJSerine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasionJ Clin Pathol201669217117526500332
  • WuFLiJDuXChimeric antibody targeting SRPK-1 in the treatment of non-small cell lung cancer by inhibiting growth, migration and invasionMol Med Rep20171622121212728656224
  • SiqueiraRPBarrosMVABarbosaÉAATrifluoromethyl aryl-amides with antileukemia effect and intracellular inhibitory activity over serine/arginine-rich protein kinases (SRPKs)Eur J Med Chem20171349710928407594
  • MorookaSHoshinaMKiiIIdentification of a dual inhibitor of SRPK1 and CK2 that attenuates pathological angiogenesis of macular degeneration in miceMol Pharmacol201588231632525993998

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.